相关实验视频
Updated: Jun 14, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.4K
简称EWSR1:介质细胞瘤瘤的乱伦之王
Emily Anne Towery1, David James Papke2
1Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Journal of clinical pathology
|August 29, 2024
概括
EWSR1基因重组是介质细胞瘤的关键驱动因素,形成各种上蛋白质. 研究突出了常见和新兴的EWSR1融合,正在调查它们在瘤中的特定作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 在中瘤中,EWSR1基因经常被重新排列.
- 这些重新排列导致了驱动瘤发展的嵌合式coproteins.
- 了解EWSR1融合对于诊断和治疗这些癌症至关重要.
研究的目的:
- 为了回顾和总结关键的EWSR1基因重组.
- 讨论既有既有和新兴的 EWSR1 融合合作伙伴.
- 突出最近关于某些EWSR1合并的特异性的发现.
主要方法:
- 对EWSR1基因重组研究的文献综述.
- 分析了各种介质细胞瘤中报告的EWSR1融合伙伴.
- 关于特定EWSR1融合的诊断实用性的最新数据的综合.
主要成果:
- 与CREB家族成员 (ATF1,CREB1) 的EWSR1融合的特征很好.
- 新兴的EWSR1融合包括EWSR1::PATZ1和EWSR1::NFATC2.2.
- 目前正在调查EWSR1::WT1和EWSR1::FLI1合并的特异性.
结论:
- EWSR1的重新排列是多种介质细胞瘤的病原体的核心.
- 对EWSR1融合变体的持续研究对于推进诊断和治疗策略至关重要.
- 准确识别EWSR1的融合伙伴有助于分类中瘤.
更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.2K
12:18LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
5.7K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K